Vasoactive intestinal peptide inhibits IL-12 and nitric oxide production in murine macrophages.

[1]  N. Ling,et al.  Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system. , 1997, Journal of immunology.

[2]  E. Shevach,et al.  Microbial products induce autoimmune disease by an IL-12-dependent pathway. , 1997, Journal of immunology.

[3]  D. Kniss,et al.  An increase in intracellular cyclic AMP modulates nitric oxide production in IFN-gamma-treated macrophages. , 1997, Journal of immunology.

[4]  G. Schuler,et al.  High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 [published erratum appears in J Exp Med 1996 Oct 1;184(4):following 1590] , 1996, The Journal of experimental medicine.

[5]  D. Pozo,et al.  Characterization of adenylyl cyclase stimulated by VIP in rat and mouse peritoneal macrophage membranes. , 1996, Biochimica et biophysica acta.

[6]  C. Brosnan,et al.  Mechanisms of Immune Injury in Multiple Sclerosis , 1996, Brain pathology.

[7]  A. Enk,et al.  Interleukin‐12 is produced by dendritic cells and mediates T helper 1 development as well as interferon‐γ production by T helper 1 cells , 1996, European journal of immunology.

[8]  M. Miller,et al.  Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. , 1996, Journal of immunology.

[9]  G. Trinchieri,et al.  The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells , 1996, The Journal of experimental medicine.

[10]  A. Alonso,et al.  Nitric oxide synthesis in rat peritoneal macrophages is induced by IgE/DNP complexes and cyclic AMP analogues. Evidence in favor of a common signaling mechanism. , 1995, Journal of immunology.

[11]  L. Aarden,et al.  Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production , 1995, The Journal of experimental medicine.

[12]  G. Trinchieri,et al.  Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. , 1994, Blood.

[13]  J. Blalock.  Shared Ligands and Receptors As a Molecular Mechanism for Communication between the Immune and Neuroendocrine Systems , 1994, Annals of the New York Academy of Sciences.

[14]  J. Miyazaki,et al.  Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  F. Marumo,et al.  Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. , 1994, The Journal of clinical investigation.

[16]  M. Delgado,et al.  VIP Gene Expression in Rat Thymus and Spleen , 1993, Brain, Behavior, and Immunity.

[17]  Lei Sun,et al.  Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex , 1993, Journal of Neuroimmunology.

[18]  S. Reichlin.  Neuroendocrine-immune interactions. , 1993, The New England journal of medicine.

[19]  F. Liew,et al.  Nitric oxide production by murine macrophages is inhibited by prolonged elevation of cyclic AMP. , 1993, Biochemical and biophysical research communications.

[20]  G. Trinchieri,et al.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.

[21]  M. Rosa,et al.  Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774 , 1992, British journal of pharmacology.

[22]  K. Decker,et al.  Regulation by prostaglandin E2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. , 1992, Biological chemistry Hoppe-Seyler.

[23]  R. Shigemoto,et al.  Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide , 1992, Neuron.

[24]  J. Leceta,et al.  Occurrence of Vasoactive Intestinal Peptide (VIP) in Lymphoid Organs from Rat and Mouse a , 1992, Annals of the New York Academy of Sciences.

[25]  G. Greenberg,et al.  High affinity specific binding of vasoactive intestinal peptide to human circulating T cells, B cells and large granular lymphocytes , 1990, Journal of Neuroimmunology.

[26]  A. Zapata,et al.  Demonstration of immunoreactive vasoactive intestinal peptide (IR-VIP) and somatostatin (IR-SOM) in rat thymus , 1990, Brain, Behavior, and Immunity.

[27]  M. O'dorisio,et al.  Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage. , 1989, Journal of immunology.

[28]  E. Goetzl,et al.  High-affinity receptors for vasoactive intestinal peptide on human myeloma cells. , 1989, Journal of immunology.

[29]  S. Asa,et al.  Vasoactive intestinal peptide-containing nerves in Peyer's patches , 1987, Brain, Behavior, and Immunity.

[30]  E. Zimmerman,et al.  Vasoactive intestinal polypeptide (VIP) in mouse and rat brain: An immunocytochemical study , 1980, Brain Research.

[31]  M. Desmazeaud,et al.  Isolement et determination de la composition qualitative de peptides issus de la caséine, stimulant la croissance de Streptococcus thermophilus , 1972 .

[32]  V. Mutt,et al.  Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. , 1972, European journal of biochemistry.

[33]  V. Mutt,et al.  Polypeptide with Broad Biological Activity: Isolation from Small Intestine , 1970, Science.

[34]  R. Sternberg.  Thinking Styles: Notes , 1997 .

[35]  G. Trinchieri.  Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.

[36]  P. Peterson,et al.  Glia, cytokines, and neurotoxicity. , 1995, Critical reviews in neurobiology.

[37]  D. Ganea,et al.  Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex. , 1994, Journal of neuroimmunology.